Gain Therapeutics Company
Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.
%20.jpg)
Last Funding Type:
Series B
Funding Status:
IPO
Headquarters:
Bethesda, Maryland, United States
Founded Date:
2017-01-01
Last Funding Date:
2020-07-21
Total Funding:
14396508.0
Estimated Revenue:
Less than $1M
Investors Number:
6.0
Industry:
Preclinical Development